Billionaire Dynasty Built on Blood Ends Reign at Troubled Empire
Over the last several decades, the Grífols family has turned the collection of blood — often from impoverished
2023-05-17 19:49
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
Biden Drops Australia, Papua New Guinea Visit for Debt Talks
President Joe Biden has scrapped planned stops in Australia and Papua New Guinea following his trip to Japan
2023-05-17 10:45
Pence Calls for End to Fed’s Jobs Role as He Weighs 2024 Bid
Former Vice President Mike Pence is calling for an end to the Federal Reserve’s dual mandate, saying the
2023-05-17 10:30
White House wants to improve access to opioid overdose reversal medication
WASHINGTON (Reuters) -President Joe Biden's administration is seeking to meet with the makers of the life-saving medication naloxone used to
2023-05-17 06:26
OpenAI chief concerned about AI being used to compromise elections
By Diane Bartz, Zeba Siddiqui and Jeffrey Dastin WASHINGTON The CEO of OpenAI, the startup behind ChatGPT, told
2023-05-17 01:17
Stardust fire victim's father was haunted by tragedy
Laura Millar told the inquest her brother James Millar, 21, had been planning to buy a house with his fiancee.
2023-05-16 21:47
Vladimir Kara-Murza's mother speaks to the BBC
Elena Gordon's son Vladimir Kara-Murza was convicted of treason for criticising Putin's war in Ukraine.
2023-05-16 13:22
US court halts ruling blocking Obamacare for some preventive healthcare
A U.S. appeals court has temporarily halted a federal judge's ruling that struck down the Affordable Care Act's
2023-05-16 10:50
FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics
The US Federal Trade Commission is expected to file a lawsuit Tuesday to block Amgen Inc.’s $27.8 billion
2023-05-16 09:22
G7 plans new vaccine effort for developing nations, Yomiuri reports
TOKYO (Reuters) -The Group of Seven (G7) rich nations is set to agree on establishing a new programme to distribute
2023-05-13 15:56
Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year, study finds
(This May 11 story has been corrected to change some wording in the quote by Dr. Mafi in paragraph 15)
2023-05-13 06:52